Your browser doesn't support javascript.
loading
Mitochondrial respiratory chain disorders in childhood: insights into diagnosis and management in the new era of genomic medicine.
Menezes, Minal J; Riley, Lisa G; Christodoulou, John.
Afiliação
  • Menezes MJ; Disciplines of Paediatrics and Child Health, Sydney Medical School, University of Sydney, New South Wales, Australia; Genetic Metabolic Disorders Research Unit, Kids Research Institute, Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Riley LG; Genetic Metabolic Disorders Research Unit, Kids Research Institute, Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Christodoulou J; Disciplines of Paediatrics and Child Health, Sydney Medical School, University of Sydney, New South Wales, Australia; Genetic Metabolic Disorders Research Unit, Kids Research Institute, Children's Hospital at Westmead, Sydney, NSW, Australia; Genetic Medicine, Sydney Medical School, University of Sydney, New South Wales, Australia. Electronic address: john.christodoulou@health.nsw.gov.au.
Biochim Biophys Acta ; 1840(4): 1368-79, 2014 Apr.
Article em En | MEDLINE | ID: mdl-24380876
ABSTRACT

BACKGROUND:

Mitochondrial respiratory chain disorders (MRCDs) are some of the most common metabolic disorders presenting in childhood, however because of it clinical heterogeneity, diagnosis is often challenging. Being a multisystemic disorder with variable and non-specific presentations, definitive diagnosis requires a combination of investigative approaches, and is often a laborious process. SCOPE OF REVIEW In this review we provide a broad overview of the clinical presentations of MRCDs in childhood, evaluating the different diagnostic approaches and treatment options, and highlighting the recent research advances in this area. MAJOR

CONCLUSIONS:

Extensive research over the years has significantly increased the frequency with which accurate diagnosis is being made, including the identification of new biomarkers and next generation sequencing (NGS) technologies. NGS has provided a breakthrough in unravelling the genetic basis of MRCDs, especially considering the complexity of mitochondrial genetics with its dual genetic contributions. GENERAL

SIGNIFICANCE:

With an increased understanding of the pathophysiology of this group of disorders, clinical trials are now being established using a number of different therapeutic approaches, with the hope of changing the focus of treatment from being largely supportive to potentially having a positive effect on the natural history of the disorder. This article is part of a Special Issue entitled Special Issue Frontiers of Mitochondria IG000218.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Genômica / Doenças Mitocondriais Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Genômica / Doenças Mitocondriais Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article